ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
09 Feb 2022

Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjärde kvartalet till den 17 februari 2022

PressmeddelandeMalmö, 9 februari, 2022 Acarix AB (publ) tidigarelägger publicering av delårsrapport för fjärde kvartalet till den 17 f...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Feb 2022

Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022

Press release Malmö, Sweden, February 9, 2022   Acarix AB (publ) brings forward publication of interim report for fourth quarter to Fe...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Feb 2022

Acarix invites to virtual Capital Market Day

Press releaseMalmö, Sweden, February 7, 2022 Acarix invites to virtual Capital Market Day Acarix is stepping up commercialization ...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Feb 2022

Acarix bjuder in till virtuell kapitalmarknadsdag

Press release Malmö, 7 februari, 2022 Acarix bjuder in till virtuell kapitalmarknadsdag Acarix, noterat på Nasdaq First North Premi...
Continue reading
author-avatar acarix
Press
August 6, 2024
10 Jan 2022

Acarix appoints US based Helen Ljungdahl Round as new CEO

Press release (MAR)Malmö, Sweden, January 10, 2022 Acarix appoints US based Helen Ljungdahl Round as new CEO The Board of Acarix AB (...
Continue reading
author-avatar acarix
Press
August 6, 2024
10 Jan 2022

Acarix utser USA-baserade Helen Ljungdahl Round till ny VD

Press release (MAR)Malmö, 10 januari, 2022 Acarix utser USA-baserade Helen Ljungdahl Round till ny VD Styrelsen för Acarix AB (publ) ...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Dec 2021

Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue

Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed right...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Dec 2021

Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemission

Press release Malmö, 29 december, 2021 Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemi...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Dec 2021

Acarix announce final outcome in rights issue

Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Compa...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Dec 2021

Acarix offentliggör slutgiltigt utfall i företrädesemission

Press release Malmö, 20 december, 2021 Acarix offentliggör slutgiltigt utfall i företrädesemission Acarix AB ("Acarix" ell...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Nov 2021

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK Extra bolagsstämman i Acarix AB ("Acarix" ell...
Continue reading
author-avatar acarix
Press
August 6, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
  • «
  • ‹
  • 18
  • 19
  • 20
  • 21
  • 22
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.